{
    "eid": "2-s2.0-85124882632",
    "title": "Long-term effectiveness of human papillomavirus vaccines among adult women: A real-world scenario",
    "cover-date": "2022-03-18",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Molecular Medicine",
            "@code": "1313",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Immunology and Microbiology (all)",
            "@code": "2400",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Veterinary (all)",
            "@code": "3400",
            "@abbrev": "VETE"
        },
        {
            "@_fa": "true",
            "$": "Public Health, Environmental and Occupational Health",
            "@code": "2739",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Cervical intraepithelial neoplasia",
        "Follow-up studies",
        "Papillomavirus vaccines",
        "Vaccine effectiveness"
    ],
    "authors": [
        "Ga Young Lee",
        "Perapong Inthasorn",
        "Piyawat Laowahutanont",
        "Saranath Lawpoolsri",
        "Supitcha Kamolratanakul",
        "Palita Lungchukiet",
        "Juhwan Oh",
        "Wichai Termrungruanglert",
        "Nimit Taechakraichana",
        "Punnee Pitisuttithum"
    ],
    "citedby-count": 3,
    "ref-count": 26,
    "ref-list": [
        "Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries",
        "Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis",
        "Epidemiology and burden of HPV-related disease",
        "Human papillomavirus vaccine introduction\u2013the first five years",
        "Prevalence of HPV After Introduction of the Vaccination Program in the United States",
        "Fall in human papillomavirus prevalence following a national vaccination program",
        "A review of clinical trials of human papillomavirus prophylactic vaccines",
        "Why consider human papillomavirus vaccination in older women?",
        "Cervical cancer in the developing world",
        "Overcoming barriers in HPV vaccination and screening programs",
        "Effectiveness of catch-up human papillomavirus vaccination on incident cervical neoplasia in a US health-care setting: a population-based case-control study",
        "Effectiveness of 1, 2, and 3 Doses of Human Papillomavirus Vaccine Against High-Grade Cervical Lesions Positive for Human Papillomavirus 16 or 18",
        "Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia",
        "Effectiveness of less than three doses of quadrivalent human papillomavirus vaccine against cervical intraepithelial neoplasia when administered using a standard dose spacing schedule: Observational cohort of young women in Australia",
        "Five-year risks of CIN 3+ and cervical cancer among women with HPV testing of ASC-US Pap results",
        "Cost-effectiveness analysis study of HPV testing as a primary cervical cancer screening in Thailand",
        "Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV study",
        "2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors",
        "Human Papillomavirus prevalence and probable first effects of vaccination in 20 to 25 year-old women in Germany: a population-based cross-sectional study via home-based self-sampling",
        "Reduction in Human Papillomavirus Vaccine Type Prevalence Among Young Women Screened for Cervical Cancer in an Integrated US Healthcare Delivery System in 2007 and 2012\u20132013",
        "Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study",
        "Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24\u201345 years: a randomised, double-blind trial",
        "Age of sexual debut among US adolescents",
        "Changes in Sexual Behavior and Attitudes Across Generations and Gender Among a Population-Based Probability Sample From an Urbanizing Province in Thailand",
        "The relationship between external contact and unmarried adolescents' and young adults' traditional beliefs in three East Asian cities: a cross-sectional analysis"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199573",
            "affilname": "Faculty of Tropical Medicine, Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199573",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": null,
            "@id": "60029487",
            "affilname": "National Cancer Institute Thailand",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029487",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60020543",
            "affilname": "Bumrungrad International Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020543",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60000656",
            "affilname": "Seoul National University College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000656",
            "affiliation-country": "South Korea"
        }
    ],
    "funding": [
        "Bumrungrad International Hospital",
        "National Cancer Institute of Thailand",
        "National Vaccine Institute",
        "Siriraj Hospital, Mahidol University",
        "Mahidol University",
        "Ministry of Public Health, Thailand",
        "Faculty of Medicine, Chulalongkorn University"
    ]
}